Cargando…
First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome
Study on long-acting growth hormone (LAGH) therapy in Turner syndrome (TS) is a 2-year retrospective study including patients diagnosed with TS from 2018–2021. Patients were divided into four groups: Group 1 to 4 were low dose (0.1 mg/kg/ w), high-dose (0.2 mg/kg/w) LAGH, daily GH (0.38 mg/kg/w), an...
Autores principales: | Gao, Xinying, Chen, Jiajia, Cao, Bingyan, Dou, Xinyu, Peng, Yaguang, Su, Chang, Qin, Miao, Wei, Liya, Fan, Lijun, Zhang, Beibei, Gong, Chunxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192150/ https://www.ncbi.nlm.nih.gov/pubmed/35504300 http://dx.doi.org/10.1055/a-1842-0724 |
Ejemplares similares
-
Correction: First Clinical Study on Long-Acting Growth Hormone Therapy in
Children with Turner Sydrome
por: Gao, Xinying, et al.
Publicado: (2023) -
DNA Hypermethylation and a Specific Methylation Spectrum on the X Chromosome in Turner Syndrome as Determined by Nanopore Sequencing
por: Fan, Xin, et al.
Publicado: (2022) -
Hormonal changes throughout puberty in boys: an observational study on the treatment outcome of congenital hypogonadotropic hypogonadism
por: Ren, Xiaoya, et al.
Publicado: (2022) -
A cross-sectional survey of adrenal steroid hormones among overweight/obese boys according to puberty stage
por: Cao, Bingyan, et al.
Publicado: (2019) -
Atypical manifestations in CAPS sydrome: not so unfrequent?
por: Buján-Rivas, S, et al.
Publicado: (2015)